Bellevue Group
$4.2B Assets Reported
195 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| VRTX | VERTEX PHARMACEUTICALS INC | 681,908 | $304M | 7.2% |
| ARGX | ARGENX SE | 313,000 | $229M | 5.4% |
| REGN | REGENERON PHARMACEUTICALS | 278,674 | $215M | 5.1% |
| SRRK | SCHOLAR ROCK HLDG CORP | 3,584,573 | $176M | 4.2% |
| GILD | GILEAD SCIENCES INC | 1,169,879 | $163M | 3.9% |
| RVMD | REVOLUTION MEDICINES INC | 1,544,456 | $150M | 3.6% |
| IONS | IONIS PHARMACEUTICALS INC | 1,818,665 | $137M | 3.2% |
| ISRG | INTUITIVE SURGICAL INC | 286,654 | $132M | 3.1% |
| VRDN | VIRIDIAN THERAPEUTICS INC | 6,726,144 | $132M | 3.1% |
| KRYS | KRYSTAL BIOTECH INC | 481,785 | $124M | 3.0% |
Track Bellevue Group's 13F portfolio: $4.2B in reported holdings, 195 positions. Top holdings, AUM, and quarterly changes on SentiSense.